AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
July 31, 2025
July 31, 2025
ST. LOUIS, Missouri, July 31 -- The Siteman Cancer Center issued the following news:
* * *
AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
By Julia Evangelou Strait, WashU Medicine
Software developed at WashU Medicine on accelerated path to approval
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of develop . . .
* * *
AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
By Julia Evangelou Strait, WashU Medicine
Software developed at WashU Medicine on accelerated path to approval
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of develop . . .